Trimethylamine
|
Basic information |
| Metabolite name | Trimethylamine |
 | HMDB0000906 |
 |
C00565 |
 |
1146 |
| Synonyms | TMA |
| No. of studies | 9 |
|
Basic information |
| Metabolite name | Trimethylamine |
| HMDB0000906 |
|
C00565 |
|
1146 |
| Synonyms | TMA |
| No. of studies | 9 |
|
Relationship between Trimethylamine and depression (count: 9) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M030 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M032 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M032 | Type2 | CUMS + venlafaxine group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M032 | Type2 | CUMS + high dose of genipin group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M032 | Type2 | CUMS + middle dose of genipin group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M032 | Type2 | CUMS + low dose of genipin group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M058 | Type1 | depressed HBV-infected patients group vs. control group and non-depressed HBV-infected group | Urine | Human | Up |
| Study M097 | Type1 | depressed men group vs. control men group | Urine | Human | Up |
| Study M1072 | Type1 | CUMS group vs. control group | Amygdala | Cynomolgus monkey | Down |
| Study M146 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Down |
| Study M146 | Type2 | CUMS + middle dose of SSO group vs. CUMS group | Urine | Sprague-Dawley rat | Up |
| Study M146 | Type2 | CUMS + high dose of SSO group vs. CUMS group | Urine | Sprague-Dawley rat | Up |
| Study M146 | Type2 | CUMS + low dose of SSO group vs. CUMS group | Urine | Sprague-Dawley rat | Up |
| Study M146 | Type2 | CUMS + venlafaxine group vs. CUMS group | Urine | Sprague-Dawley rat | Up |
| Study M207 | Type1 | depressed group vs. control group | Faece | Kunming mouse | Down |
| Study M614 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M950 | Type2 | probiotic group, after treatment vs. baseline | Faece | Human | Up |